Long-term maraviroc use as salvage therapy in HIV-2 infection

Caixas, UmbelinaFerreira, JoanaMarinho, Aline T.Faustino, InêsGrilo, Nádia M.Lampreia, FátimaGermano, IsabelMonteiro, Emília C.Monteiro, E.C.Pereira, Sofia A.SA, Pereira2023-12-282023-12-282012-10-010305-7453PURE: 5313000PURE UUID: 8d1ef3fe-1b80-4de8-aacc-91bed1bf09f5Scopus: 84866613168PubMed: 22729923WOS: 000309140900042ORCID: /0000-0002-8456-9995/work/59470824http://hdl.handle.net/10362/1617112136184engCCR5 antagonistsHIV-2 CCR5 tropismPersistent low CD4 cell countSecond-line HIV-2 therapyTherapeutic drug monitoringPharmacologyPharmacology (medical)Infectious DiseasesSDG 3 - Good Health and Well-beingLong-term maraviroc use as salvage therapy in HIV-2 infectionjournal article10.1093/jac/dks240https://www.scopus.com/pages/publications/84866613168